test

An Exploratory Study to Investigate the Immunomodulatory Activity of Various Dose Levels of Anti Programmed-Deach-1 (PD-1) Antibody (BMS-936558) in Subjects with Metastatic Clear Cell Renal Cell Carcinoma (RCC)

Conditions

Renal Cell Carcinoma | Renal Cell Carcinoma (RCC)

Trial Phase

Trial Purpose and Description

Trial Purpose


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Eligibility Criteria

Sponsor:
Bristol-Myers Squibb
Dates:
July 2011
Last Updated:
Study HIC#:
1105008541